Company: LGNZZ
Filing Date: 2025-04-22
Form Type: DEF 14A
Source: 0000886163-25-000025
Chunk: 29

Company: LIGAND PHARMACEUTICALS INC
Filing Date: 2025-04-22
Form: DEF 14A
Chunk 29
---
 shares of common stock Dr. LaMattina has the right to acquire pursuant to outstanding options which are exercisable within 60 days of the Record Date.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| (12) |     | Consists of (i) 4,397 shares of common stock, (ii) 1,252 shares of common stock issuable to Mr. Haas upon settlement of outstanding restricted stock units which will vest within 60 days after the Record Date, and (iii) 17,664 shares of common stock Mr. Haas has the right to acquire pursuant to outstanding options which are exercisable within 60 days of the Record Date.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| (13) |     | Consists of (i) 32,584 shares of common stock, (ii) 1,252 shares of common stock issuable to Dr. Sabba upon settlement of outstanding restricted stock units which will vest within 60 days of the Record Date, and (iii) 71,260 shares of common stock Dr. Sabba has the right to acquire pursuant to outstanding options which are exercisable within 60 days of the Record Date.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| (14) |     | Consists of (i) 2,014 shares of common stock, (ii) 1,252 shares of common stock issuable to Dr. Zimmermann upon settlement of outstanding restricted stock units which will vest within 60 days of the Record Date, and (iii) 9,226 shares of common stock Dr. Zimmermann has the right to acquire pursuant to outstanding options which are exercisable within 60 days of the Record Date.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| (15) |     | The number and percentage of shares beneficially owned excludes the number of shares which are subject to restricted stock units and held by the applicable individual that are not scheduled to vest within 60 days of the Record Date.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |

25

#### DELINQUENT SECTION 16(a) REPORTS
Section 16(a) of the Exchange Act requires our directors, officers and beneficial owners of 10% or more of our common stock to file reports with the SEC. We assist our directors and officers by monitoring transactions and completing and filing these reports on their behalf. Based on our records and other information, we believe that all reports that were required to be filed under Section 16(a) during 2024 were timely filed, other than one Form 4 for Mr. Sab